Invitation to the presentation of ALK’s annual report 2025 on Friday, 20 February 2026

Core Viewpoint - ALK will publish its annual report for 2025 on February 20, 2026, and will host a presentation for investors and analysts later that day to discuss results and outlook [1]. Group 1: Annual Report and Presentation - The annual report for 2025 will be released in the morning on February 20, 2026 [1]. - A presentation for investors and analysts will take place at 1:30 p.m. CET on the same day, featuring comments from ALK's management [1]. - Key representatives from ALK during the presentation will include Peter Halling (President & CEO), Claus Steensen Sølje (CFO), and Per Plotnikof (VP, Head of IR) [1]. Group 2: Participation and Access - The presentation will be available via live audio webcast and can be replayed on ALK's website [2]. - For those wishing to participate via telephone, registration is required, and details will be provided via email after registration [3]. - The presentation materials will be accessible on ALK's website shortly before the meeting starts [4]. Group 3: Company Overview - ALK is a global specialty pharmaceutical company focused on allergy, covering the entire value chain from development to marketing of products for diagnosing and treating respiratory allergies and anaphylaxis [6]. - The company is headquartered in Denmark and employs approximately 2,700 people worldwide, listed on Nasdaq Copenhagen [6].